Detalhe da pesquisa
1.
N7-Methylguanosine tRNA modification enhances oncogenic mRNA translation and promotes intrahepatic cholangiocarcinoma progression.
Mol Cell
; 81(16): 3339-3355.e8, 2021 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34352206
2.
Hypoxia-driven tumor stromal remodeling and immunosuppressive microenvironment in scirrhous HCC.
Hepatology
; 79(4): 780-797, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37725755
3.
Spatial proteomics of immune microenvironment in nonalcoholic steatohepatitis-associated hepatocellular carcinoma.
Hepatology
; 79(3): 560-574, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37733002
4.
A TGF-ß-dominant chemoresistant phenotype of hepatoblastoma associated with aflatoxin exposure in children.
Hepatology
; 79(3): 650-665, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37459556
5.
Predicting 5-year recurrence risk in colorectal cancer: development and validation of a histology-based deep learning approach.
Br J Cancer
; 130(6): 951-960, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38245662
6.
FASN-mediated fatty acid biosynthesis remodels immune environment in Clonorchis sinensis infection-related intrahepatic cholangiocarcinoma.
J Hepatol
; 2024 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38508240
7.
Single-cell profiling reveals kidney CD163+ dendritic cell participation in human lupus nephritis.
Ann Rheum Dis
; 83(5): 608-623, 2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38290829
8.
Methyltransferase 1 is required for nonhomologous end-joining repair and renders hepatocellular carcinoma resistant to radiotherapy.
Hepatology
; 77(6): 1896-1910, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35698894
9.
Eliminating METTL1-mediated accumulation of PMN-MDSCs prevents hepatocellular carcinoma recurrence after radiofrequency ablation.
Hepatology
; 77(4): 1122-1138, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35598182
10.
Targeting N7-methylguanosine tRNA modification blocks hepatocellular carcinoma metastasis after insufficient radiofrequency ablation.
Mol Ther
; 31(6): 1596-1614, 2023 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35965412
11.
METTL5-mediated 18S rRNA m6A modification promotes oncogenic mRNA translation and intrahepatic cholangiocarcinoma progression.
Mol Ther
; 31(11): 3225-3242, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37735874
12.
Targeting tumour-intrinsic N7-methylguanosine tRNA modification inhibits MDSC recruitment and improves anti-PD-1 efficacy.
Gut
; 72(8): 1555-1567, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36283801
13.
Distinct single-cell immune ecosystems distinguish true and de novo HBV-related hepatocellular carcinoma recurrences.
Gut
; 72(6): 1196-1210, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36596711
14.
The activation of mTOR signalling modulates DNA methylation by enhancing DNMT1 translation in hepatocellular carcinoma.
J Transl Med
; 21(1): 276, 2023 04 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37088830
15.
Effect of inactivated COVID-19 vaccine on the negative conversion of nucleic acid in asymptomatic or mild patients with COVID-19.
BMC Infect Dis
; 23(1): 443, 2023 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37391716
16.
Removal of Chromium Species by Adsorption: Fundamental Principles, Newly Developed Adsorbents and Future Perspectives.
Molecules
; 28(2)2023 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36677697
17.
Insufficient Radiofrequency Ablation Promotes Hepatocellular Carcinoma Metastasis Through N6-Methyladenosine mRNA Methylation-Dependent Mechanism.
Hepatology
; 74(3): 1339-1356, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33638162
18.
Non-invasive diagnosis strategy of hepatocellular carcinoma in low-risk population.
BMC Cancer
; 22(1): 709, 2022 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35761201
19.
Prediction of microvascular invasion in hepatocellular carcinoma with expert-inspiration and skeleton sharing deep learning.
Liver Int
; 42(6): 1423-1431, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35319151
20.
The impact of circadian rhythms on the immune response to influenza vaccination in middle-aged and older adults (IMPROVE): a randomised controlled trial.
Immun Ageing
; 19(1): 46, 2022 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36253778